IRONWOOD PHARMACEUTICALS
Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company, engages in developing and marketing human medicines. It engages in developing a pipeline of clinical candidates in the areas of gastrointestinal diseases, cardiovascular diseases, pain, and inflammation. The company's operationally independent subsidiary, Microbia Inc., engages in developing and commercializing bioprocesses for use in pharmaceuticals, foods, and specialty and industrial chemicals. Ironwood Pharmaceuticals, Inc. was formerly known as Microbia, Inc. The company was founded in 1998 and is headquartered in Cambridge, Massachusetts.
IRONWOOD PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1998-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.ironwoodpharma.com
Total Employee:
501+
Status:
Active
Contact:
617-621-7722
Email Addresses:
[email protected]
Total Funding:
634 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Polaris Partners
Polaris Partners investment in Venture Round - Ironwood Pharmaceuticals
Venrock
Venrock investment in Series F - Ironwood Pharmaceuticals
Morgan Stanley
Morgan Stanley investment in Series F - Ironwood Pharmaceuticals
Venrock
Venrock investment in Series E - Ironwood Pharmaceuticals
Venrock
Venrock investment in Series D - Ironwood Pharmaceuticals
GGV Capital
GGV Capital investment in Series D - Ironwood Pharmaceuticals
Venrock
Venrock investment in Series C - Ironwood Pharmaceuticals
F-Prime Capital
F-Prime Capital investment in Series C - Ironwood Pharmaceuticals
Venrock
Venrock investment in Series B - Ironwood Pharmaceuticals
Venrock
Venrock investment in Series A - Ironwood Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-01 | Ironwood Pharmaceuticals Appoints Sravan K. Emany as Chief Financial Officer |
| 2021-08-03 | Ironwood Pharmaceuticals Appoints John Minardo as Chief Legal Officer |
| 2021-02-08 | Ironwood Pharmaceuticals Announces CEO Transition |
Official Site Inspections
http://www.ironwoodpharma.com Semrush global rank: 3.97 M Semrush visits lastest month: 3.12 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Ironwood Pharmaceuticals"
Leadership - Ironwood Pharmaceuticals
Mr. Minardo has served as our chief legal officer since August 2021. Prior to joining Ironwood, Mr. Minardo was with Seqirus, a pharmaceutical company, where he was vice president, general …See details»
Governance Documents - Ironwood Pharmaceuticals
Nov 27, 2024 The Board of Directors of Ironwood Pharmaceuticals, Inc. (the "Company") sets high standards for the Company's employees, officers and directors.See details»
Company Overview - Ironwood Pharmaceuticals
Ironwood Pharmaceuticals is a patient-focused, biopharmaceutical company on a mission to push the boundaries of the gastrointestinal (GI) field by advancing the treatment of GI diseases and redefining the standard of care for millions of …See details»
Ironwood Pharmaceuticals, Inc. - Company Overview
Nov 7, 2024 Ironwood Pharmaceuticals (Nasdaq: IRWD), an S&P SmallCap 600® company, is a leading global gastrointestinal (GI) healthcare company on a mission to advance the treatment …See details»
Ironwood Pharmaceuticals - Crunchbase Company …
Contact Email [email protected] Phone Number 617-621-7722 Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company, engages in developing and marketing human medicines.See details»
Working at Ironwood Pharmaceuticals - Zippia
Mar 14, 2024 www.ironwoodpharma.com. Organization Type. Public. CEO. Thomas McCourt. Social Media. Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company, engages in developing and marketing human …See details»
Ironwood Pharmaceuticals, Inc. (Ironwood Pharmaceuticals, Inc.)
We routinely post information that may be important to investors on our website at . In addition, follow us on Twitter and on LinkedIn . Contacts Investors: Greg Martini, 617-374-5230 …See details»
Ironwood Pharmaceuticals, Inc. - Corporate …
Nov 27, 2024 Peter Hecht has served as Ironwood’s CEO and a director since co‐founding the company in 1998. He started Ironwood because he was attracted to “the idea of working with a team of people who challenge, inspire and …See details»
Working at Ironwood - Ironwood Pharmaceuticals
WORKING AT IRONWOOD PHARMACEUTICALS When I think of all of the work Ironwood as an organization has done to impact patients and impact their lives positively, that is a huge motivator for me and definitely a reason that I love …See details»
Ironwood Pharmaceuticals - Overview, News & Similar companies ...
Jun 22, 2024 Ironwood Pharmaceuticals contact info: Phone number: (617) 621-8097 Website: www.ironwoodpharma.com What does Ironwood Pharmaceuticals do? Ironwood …See details»
Ironwood Pharmaceuticals Announces Leadership Updates
Jun 7, 2021 Investors and Media: Meredith Kaya, 617-374-5082 [email protected] Matt Roache, 617-621-8395 [email protected] Media: Beth Calitri, 978-417 …See details»
Overview - Ironwood Pharmaceuticals
We are conducting clinical studies of investigational medicines for serious, rare disorders. We remain committed to making our medicines available as quickly as we can to appropriate …See details»
Ironwood Pharmaceuticals Announces Leadership Updates
Jun 7, 2021 She built a strong and effective finance organization, and today, Ironwood is proud to have delivered two years of profitability, supported by a robust balance sheet and strong …See details»
Ironwood Pharmaceuticals, Inc. - Ironwood Pharmaceuticals to ...
Nov 26, 2024 Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that management will participate in a fireside chat at the Piper Sandler 36 th Annual Healthcare …See details»
Ironwood Pharmaceuticals to Participate in the Jefferies London ...
Nov 13, 2024 Ironwood Pharmaceuticals, Inc. today announced that Sravan Emany, Chief Operating Officer and Chief Financial Officer, will participate in a fireside chat at the Jefferies …See details»
Overview - Ironwood Pharmaceuticals
Our culture is one that prioritizes sustainability in everything we do. From recruiting and retaining our talented employees, to overseeing our internal processes, to remaining mindful of our …See details»
Ironwood Pharmaceuticals Announces CEO Transition
Feb 8, 2021 – Mark Mallon to step down as CEO; Board appoints Thomas McCourt as interim CEO – – Julie McHugh to become Executive Chair of the Board of Directors – Ironwood …See details»
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year …
Feb 15, 2024 Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI …See details»
Ironwood Pharmaceuticals to Participate in the Jefferies London ...
Nov 13, 2024 Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that Sravan Emany, Chief Operating Officer and Chief Financial Officer, will participate in a fireside chat at …See details»